Novel potential targets for prevention of arterial restenosis: Insights from the pre-clinical research

Clinical Science

Volumn 127, Issue 11, 2014, Pages 615-634

  Forte, Amalia ^a   Rinaldi, Barbara ^a   Berrino, Liberato ^a   Rossi, Francesco ^a   Galderisi, Umberto ^a   Cipollaro, Marilena ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Animal model; Gene therapy; microRNA; Pharmacogenomics; Restenosis; Stem cell

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ATRIAL NATRIURETIC FACTOR; CORTISTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; MICRORNA; NUCLEAR FACTOR Y; PACLITAXEL; PROTEIN P53; QUERCETIN; RAPAMYCIN; RESVERATROL; ROSIGLITAZONE; S ADENOSYLMETHIONINE; SALSALATE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRICHOSTATIN A; VINPOCETINE; ZOTAROLIMUS;

BARE METAL STENT; CARDIOVASCULAR EQUIPMENT; CELL MIGRATION; CELL PROLIFERATION; CLINICAL RESEARCH; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING BALLOON; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; GENE THERAPY; HUMAN; IN-STENT RESTENOSIS; MESENCHYMAL STEM CELL; NITINOL STENT; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CORONARY RESTENOSIS; GENETIC THERAPY; MALE; MICE; MICRORNAS; MODELS, ANIMAL; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; RATS, WISTAR; REGENERATION; STEM CELLS;

EID: 84905917677     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140131     Document Type: Review

References (161)

1. Alberts, M. J., Bhatt, D. L., Mas, J. L., Ohman, E. M., Hirsch, A. T., Rother, J., Salette, G., Goto, S., Smith, Jr, S. C., Liau, C. S. et al. (2009) Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur. Heart J. 30, 2318-2326
2. Frostegard, J. (2013) Immunity, atherosclerosis and cardiovascular disease. BMC Med. 11, 117
3. Jashari, F., Ibrahimi, P., Nicoll, R., Bajraktari, G., Wester, P. and Henein, M. Y. (2013) Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis 227, 193-200
4. Yin, J. H., Song, Z. Y., Shan, P. F., Xu, J., Ye, Z. M., Xu, X. H., Zhang, S. Z., Liang, Q., Zhao, Y., Ren, Z. and Yu, Y. P. (2012) Age- and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China. Clin. Endocrinol. 76, 802-809
5. Zeb, I., Li, D., Nasir, K., Malpeso, J., Batool, A., Flores, F., Dailing, C., Karlsberg, R. P. and Budoff, M. (2013) Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study. Atherosclerosis 231, 198-204
6. Laird, J. R. and Dawson, D. L. (2009) The role for cryoplasty in the treatment of infrainguinal artery disease: case studies. J. Endovasc. Ther. 16, (2 Suppl. 2) II116-II128
7. Gruntzig, A. R., Senning, A. and Siegenthaler, W. E. (1979) Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 301, 61-68
8. Sigwart, U., Puel, J., Mirkovitch, V., Joffre, F. and Kappenberger, L. (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N. Engl. J. Med. 316, 701-706
9. Bajaj, N. R. and Garratt, K. N. (2010) Clinical studies with paclitaxel-eluting stent systems. Curr. Pharm. Des. 16, 4025-4036
10. Silber, S., Colombo, A., Banning, A. P., Hauptmann, K., Drzewiecki, J., Grube, E., Dudek, D. and Baim, D. S. (2009) Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. Circulation 120, 1498-1504
11. Justice, J. and Yacono, C. (2009) Use of drug-eluting stents for patients with coronary heart disease. JAAPA 22, 30-34
12. Raber, L., Kelbaek, H., Ostojic, M., Baumbach, A., Heg, D., Tuller, D., von Birgelen, C., Roffi, M., Moschovitis, A., Khattab, A. A. et al. (2012) Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA 308, 777-787
13. Palmerini, T., Biondi-Zoccai, G., Della Riva, D., Mariani, A., Sabate, M., Smits, P. C., Kaiser, C., D'Ascenzo, F., Frati, G., Mancone, M. et al. (2014) Clinical outcomes with bioabsorbable polymer-based versus durable polymer-based drug-eluting stents and bare metal stents: evidence from a comprehensive network meta-analysis. J. Am. Coll. Cardiol. 63, 299-307
14. Costopoulos, C., Latib, A., Naganuma, T., Sticchi, A., Figini, F., Basavarajaiah, S., Carlino, M., Chieffo, A., Montorfano, M., Naim, C. et al. (2013) The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease. JACC Cardiovasc. Interv. 6, 1153-1159
15. Cale, R., Sousa, P. J., Pereira, E., Araujo Goncalves, P., Vitorino, S., Vinhas, H., Raposo, L., Martins, C., Mesquita Gabriel, H., Campante Teles, R. et al. (2013) One-year clinical outcomes of percutaneous treatment with drug-eluting balloons: results from a multicenter registry. Rev. Port. Cardiol. 32, 361-369
16. Lupi, A., Rognoni, A., Secco, G. G., Porto, I., Nardi, F., Lazzero, M., Rossi, L., Parisi, R., Fattori, R., Genoni, G. et al. (2013) Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients. Int. J. Cardiol. 168, 4608-4616
17. Waksman, R. and Pakala, R. (2009) Drug-eluting balloon: the comeback kid? Circ. Cardiovasc. Interv. 2, 352-358
18. Scheller, B., Hehrlein, C., Bocksch, W., Rutsch, W., Haghi, D., Dietz, U., Bohm, M. and Speck, U. (2008) Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. 97, 773-781
19. Seedial, S. M., Ghosh, S., Saunders, R. S., Suwanabol, P. A., Shi, X., Liu, B. and Kent, K. C. (2013) Local drug delivery to prevent restenosis. J. Vasc. Surg. 57, 1403-1414
20. Murray, G. (1953) Blood vessel surgery. Can. Med. Assoc. J 69, 296-299
21. Smith, S., Beasley, M., Hodes, R., Hall, H., Biel, E. and Huth, E. W. (1957) Auxiliary myocardial vascularization by prosthetic graft implantation. Surg. Gynecol. Obstet. 104, 263-268
22. Aydin, S., Aydin, S., Nesimi Eren, M., Sahin, I., Yilmaz, M., Kalayci, M. and Gungor, O. (2013) The cardiovascular system and the biochemistry of grafts used in heart surgery. Springerplus 2, 612
23. Petty, G. W., Brown, Jr, R. D., Whisnant, J. P., Sicks, J. D., O'Fallon, W. M. and Wiebers, D. O. (1999) Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 30, 2513-2516
24. Brooks, W. H., Jones, M. R., Gisler, P., McClure, R. R., Coleman, T. C., Breathitt, L. and Spear, C. (2014) Carotid angioplasty with stenting versus endarterectomy: 10-year randomized trial in a community hospital. JACC Cardiovasc. Interv. 7, 163-168
25. Rantner, B., Goebel, G., Bonati, L. H., Ringleb, P. A., Mas, J. L. and Fraedrich, G. (2013) The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms. J. Vasc. Surg. 57, 619-626, e612
26. Lesperance, J., Bourassa, M. G., Schwartz, L., Hudon, G., Laurier, J., Eastwood, C. and Kazim, F. (1993) Definition and measurement of restenosis after successful coronary angioplasty: implications for clinical trials. Am. Heart J. 125, 1394-1408
27. Mintz, G. S., Popma, J. J., Pichard, A. D., Kent, K. M., Satler, L. F., Wong, C., Hong, M. K., Kovach, J. A. and Leon, M. B. (1996) Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94, 35-43
28. Weintraub, W. S. (2007) The pathophysiology and burden of restenosis. Am. J. Cardiol. 100, 3K-9K
29. Goel, S. A., Guo, L. W., Liu, B. and Kent, K. C. (2012) Mechanisms of post-intervention arterial remodelling. Cardiovasc. Res. 96, 363-371
30. Hosono, M., Ueda, M., Suehiro, S., Sasaki, Y., Shibata, T., Hattori, K. and Kinoshita, H. (2000) Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis. J. Thorac. Cardiovasc. Surg. 120, 319-328
31. Myit, S., Delafontaine, P., Bochaton-Piallat, M. L., Giraud, S., Gabbiani, G. and Brink, M. (2003) Different growth properties of neointimal and medial smooth muscle cells in response to growth factors. J. Vasc. Res. 40, 97-104
32. Shanahan, C. M. and Weissberg, P. L. (1998) Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 18, 333-338
33. Mori, F., Nakayama, T., Matsuzawa, T. and Ohta, M. (2012) Observation of the expansion behavior and quantitative evaluation of elastic recoil of a balloon-expandable stent in three dimensions using a Micro-CT system. Technol. Health Care 20, 305-315
34. Maeng, M., Olesen, P. G., Emmertsen, N. C., Thorwest, M., Nielsen, T. T., Kristensen, B. O., Falk, E. and Andersen, H. R. (2001) Time course of vascular remodeling, formation of neointima and formation of neoadventitia after angioplasty in a porcine model. Coron. Artery Dis. 12, 285-293
35. Lingman, M., Albertsson, P., Herlitz, J., Bergfeldt, L. and Lagerqvist, B. (2011) The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary intervention. Am. J. Med. 124, 265-275
36. Russo, R. J., Silva, P. D. and Yeager, M. (2007) Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model. Heart 93, 1609-1615
37. Ma, X., Hibbert, B., McNulty, M., Hu, T., Zhao, X., Ramirez, F. D., Simard, T., de Belleroche, J. S. and O'Brien, E. R. (2014) Heat shock protein 27 attenuates neointima formation and accelerates reendothelialization after arterial injury and stent implantation: importance of vascular endothelial growth factor up-regulation. FASEB J. 28, 594-602
38. Oyamada, S., Ma, X., Wu, T., Robich, M. P., Wu, H., Wang, X., Buchholz, B., McCarthy, S., Bianchi, C. F., Sellke, F. W. and Laham, R. (2011) Trans-iliac rat aorta stenting: a novel high throughput preclinical stent model for restenosis and thrombosis. J. Surg. Res. 166, e91-e95
39. Simsekyilmaz, S., Schreiber, F., Weinandy, S., Gremse, F., Sonmez, T. T. and Liehn, E. A. (2013) A murine model of stent implantation in the carotid artery for the study of restenosis. J. Vis. Exp. e50233
40. Jeremy, J. Y. and Thomas, A. C. (2010) Animal models for studying neointima formation. Curr. Vasc. Pharmacol. 8, 198-219
41. Li, P., Zhu, N., Yi, B., Wang, N., Chen, M., You, X., Zhao, X., Solomides, C. C., Qin, Y. and Sun, J. (2013) MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ. Res. 113, 1117-1127
42. Shen, H., Eguchi, K., Kono, N., Fujiu, K., Matsumoto, S., Shibata, M., Oishi-Tanaka, Y., Komuro, I., Arai, H., Nagai, R. and Manabe, I. (2013) Saturated fatty acid palmitate aggravates neointima formation by promoting smooth muscle phenotypic modulation. Arterioscler. Thromb. Vasc. Biol. 33, 2596-2607
43. Forte, A., Di Micco, G., Galderisi, U., Guarino, F. M., Cipollaro, M., De Feo, M., Gregorio, R., Bianco, M. R., Vollono, C., Esposito, F. et al. (2001) Molecular analysis of arterial stenosis in rat carotids. J. Cell. Physiol. 186, 307-313
44. Forte, A., Finicelli, M., De Luca, P., Quarto, C., Onorati, F., Sante, P., Renzulli, A., Galderisi, U., Berrino, L., De Feo, M. et al. (2008) Expression profiles in surgically-induced carotid stenosis: a combined transcriptomic and proteomic investigation. J. Cell. Mol. Med. 12, 1956-1973
45. Forte, A., Finicelli, M., Mattia, M., Berrino, L., Rossi, F., De Feo, M., Cotrufo, M., Cipollaro, M., Cascino, A. and Galderisi, U. (2008) Mesenchymal stem cells effectively reduce surgically induced stenosis in rat carotids. J. Cell. Physiol. 217, 789-799
46. Liu, W., Wang, J., Chen, C., Zhou, F., Zhou, Y. and Zhang, F. (2013) The effects of Batroxobin on the intimal hyperplasia of graft veins. Am. J. Surg. 206, 594-598
47. Hu, Z. J., Li, Z. L., Hu, L. Y., He, W., Liu, R. M., Qin, Y. S. and Wang, S. M. (2012) The in vivo performance of small-caliber nanofibrous polyurethane vascular grafts. BMC Cardiovasc. Disord. 12, 115
48. Kim, J. H., Shin, J. H., Shin, D. H., Moon, M. W., Park, K., Kim, T. H., Shin, K. M., Won, Y. H., Han, D. K. and Lee, K. R. (2011) Comparison of diamond-like carbon-coated nitinol stents with or without polyethylene glycol grafting and uncoated nitinol stents in a canine iliac artery model. Br. J. Radiol. 84, 210-215
49. Zaragoza, C., Gomez-Guerrero, C., Martin-Ventura, J. L., Blanco-Colio, L., Lavin, B., Mallavia, B., Tarin, C., Mas, S., Ortiz, A. and Egido, J. (2011) Animal models of cardiovascular diseases. J. Biomed. Biotechnol. 2011, 497841
50. Schwartz, R. S., Chronos, N. A. and Virmani, R. (2004) Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J. Am. Coll. Cardiol. 44, 1373-1385
51. Perkins, L. E. (2010) Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems. Vet. Pathol. 47, 58-76
52. Zhang, Y., Xi, Q., Ding, J., Cai, W., Meng, F., Zhou, J., Li, H., Jiang, Q., Shu, G., Wang, S. et al. (2012) Production of transgenic pigs mediated by pseudotyped lentivirus and sperm. PLoS ONE 7, e35335
53. Thim, T., Hagensen, M. K., Drouet, L., Bal Dit Sollier, C., Bonneau, M., Granada, J. F., Nielsen, L. B., Paaske, W. P., Botker, H. E. and Falk, E. (2010) Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies. EuroIntervention 6, 261-268
54. Touchard, A. G. and Schwartz, R. S. (2006) Preclinical restenosis models: challenges and successes. Toxicol. Pathol. 34, 11-18
55. Tsai, T. N., Kirton, J. P., Campagnolo, P., Zhang, L., Xiao, Q., Zhang, Z., Wang, W., Hu, Y. and Xu, Q. (2012) Contribution of stem cells to neointimal formation of decellularized vessel grafts in a novel mouse model. Am. J. Pathol. 181, 362-373
56. Chen, Y., Wong, M. M., Campagnolo, P., Simpson, R., Winkler, B., Margariti, A., Hu, Y. and Xu, Q. (2013) Adventitial stem cells in vein grafts display multilineage potential that contributes to neointimal formation. Arterioscler. Thromb. Vasc. Biol. 33, 1844-1851
57. Tigges, U., Komatsu, M. and Stallcup, W. B. (2013) Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury. J. Vasc. Res. 50, 134-144
58. Wan, M., Li, C., Zhen, G., Jiao, K., He, W., Jia, X., Wang, W., Shi, C., Xing, Q., Chen, Y. F. et al. (2012) Injury-activated transforming growth factor ß controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells 30, 2498-2511
59. Ferreira, L. M. and Mostajo-Radji, M. A. (2013) How induced pluripotent stem cells are redefining personalized medicine. Gene 520, 1-6
60. Yamamoto, T., Shibata, R., Ishii, M., Kanemura, N., Kito, T., Suzuki, H., Miyake, H., Maeda, K., Tanigawa, T., Ouchi, N. and Murohara, T. (2013) Therapeutic reendothelialization by induced pluripotent stem cells after vascular injury - brief report. Arterioscler. Thromb. Vasc. Biol. 33, 2218-2221
61. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S. and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147
62. Beggs, K. J., Lyubimov, A., Borneman, J. N., Bartholomew, A., Moseley, A., Dodds, R., Archambault, M. P., Smith, A. K. and McIntosh, K. R. (2006) Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant. 15, 711-721
63. Caplan, A. I. and Dennis, J. E. (2006) Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98, 1076-1084
64. Forte, A., Rinaldi, B., Sodano, L., Berrino, L., Rossi, F., Finicelli, M., Grossi, M., Cobellis, G., Botti, C., De Feo, M. et al. (2012) Stem cell therapy for arterial restenosis: potential parameters contributing to the success of bone marrow-derived mesenchymal stromal cells. Cardiovasc. Drugs Ther. 26, 9-21
65. Shoji, M., Oskowitz, A., Malone, C. D., Prockop, D. J. and Pochampally, R. (2011) Human mesenchymal stromal cells (MSCs) reduce neointimal hyperplasia in a mouse model of flow-restriction by transient suppression of anti-inflammatory cytokines. J. Atheroscler. Thromb. 18, 464-474
66. Huang, W. C., Newby, G. B., Lewis, A. L., Stratford, P. W., Rogers, C. A., Newby, A. C. and Murphy, G. J. (2013) Periadventitial human stem cell treatment reduces vein graft intimal thickening in pig vein-into-artery interposition grafts. J. Surg. Res. 183, 33-39
67. Wang, C. H., Cherng, W. J., Yang, N. I., Kuo, L. T., Hsu, C. M., Yeh, H. I., Lan, Y. J., Yeh, C. H. and Stanford, W. L. (2008) Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler. Thromb. Vasc. Biol. 28, 54-60
68. Cui, B., Huang, L., Fang, Y., Guo, R., Yin, Y. and Zhao, X. (2011) Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation. Microvasc. Res. 81, 143-150
69. Yang, F., Feng, S. C., Pang, X. J., Li, W. X., Bi, Y. H., Zhao, Q., Zhang, S. X., Wang, Y. and Feng, B. (2012) Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation. BMC Cardiovasc. Disord. 12, 96
70. Sethi, R. and Lee, C. H. (2012) Endothelial progenitor cell capture stent: safety and effectiveness. J. Interv. Cardiol. 25, 493-500
71. Lee, J. M., Choe, W., Kim, B. K., Seo, W. W., Lim, W. H., Kang, C. K., Kyeong, S., Eom, K. D., Cho, H. J., Kim, Y. C. et al. (2012) Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin. Biomaterials 33, 8917-8927
72. Haude, M., Lee, S. W., Worthley, S. G., Silber, S., Verheye, S., Erbs, S., Rosli, M. A., Botelho, R., Meredith, I., Sim, K. H. et al. (2013) The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. JACC Cardiovasc. Interv. 6, 334-343
73. Wong, M. M., Winkler, B., Karamariti, E., Wang, X., Yu, B., Simpson, R., Chen, T., Margariti, A. and Xu, Q. (2013) Sirolimus stimulates vascular stem/progenitor cell migration and differentiation into smooth muscle cells via epidermal growth factor receptor/extracellular signal-regulated kinase/ß-catenin signaling pathway. Arterioscler. Thromb. Vasc. Biol. 33, 2397-2406
74. Iwata, Y., Fujimoto, Y., Morino, T., Sugimoto, K., Ohkubo, K., Kadohira, T., Fukushima, K., Kitahara, H., Komuro, I. and Kobayashi, Y. (2013) Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial. Am. Heart J. 165, 408-414
75. Yamauchi, A., Kawabe, J., Kabara, M., Matsuki, M., Asanome, A., Aonuma, T., Ohta, H., Takehara, N., Kitagawa, T. and Hasebe, N. (2013) Apurinic/apyrimidinic endonucelase 1 maintains adhesion of endothelial progenitor cells and reduces neointima formation. Am. J. Physiol. Heart Circ. Physiol. 305, H1158-H1167
76. Hagensen, M. K., Raarup, M. K., Mortensen, M. B., Thim, T., Nyengaard, J. R., Falk, E. and Bentzon, J. F. (2012) Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc. Res. 93, 223-231
77. Schrepfer, S., Deuse, T., Reichenspurner, H., Fischbein, M. P., Robbins, R. C. and Pelletier, M. P. (2007) Stem cell transplantation: the lung barrier. Transplant. Proc. 39, 573-576
78. Albinsson, S., Suarez, Y., Skoura, A., Offermanns, S., Miano, J. M. and Sessa, W. C. (2010) MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler. Thromb. Vasc. Biol. 30, 1118-1126
79. Albinsson, S. and Sward, K. (2013) Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease. Pharmacol. Res. 75, 28-36
80. Choe, N., Kwon, J. S., Kim, J. R., Eom, G. H., Kim, Y., Nam, K. I., Ahn, Y., Kee, H. J. and Kook, H. (2013) The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 229, 348-355
81. Wang, Y. S., Wang, H. Y., Liao, Y. C., Tsai, P. C., Chen, K. C., Cheng, H. Y., Lin, R. T. and Juo, S. H. (2012) MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Cardiovasc. Res. 95, 517-526
82. Iaconetti, C., Polimeni, A., Sorrentino, S., Sabatino, J., Pironti, G., Esposito, G., Curcio, A. and Indolfi, C. (2012) Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Basic Res. Cardiol. 107, 296
83. Liu, X., Cheng, Y., Yang, J., Xu, L. and Zhang, C. (2012) Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J. Mol. Cell. Cardiol. 52, 245-255
84. Jakob, P. and Landmesser, U. (2012) Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc. Res. 93, 614-622
85. Kaudewitz, D., Lee, R., Willeit, P., McGregor, R., Markus, H. S., Kiechl, S., Zampetaki, A., Storey, R. F., Channon, K. M. and Mayr, M. (2013) Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb. Haemost. 110, 609-615
86. Bult, H. (2000) Restenosis: a challenge for pharmacology. Trends Pharmacol. Sci. 21, 274-279
87. Simon, D. I., Dhen, Z., Seifert, P., Edelman, E. R., Ballantyne, C. M. and Rogers, C. (2000) Decreased neointimal formation in Mac-1-/- mice reveals a role for inflammation in vascular repair after angioplasty. J. Clin. Invest. 105, 293-300
88. Simon, D. I. (2012) Inflammation and vascular injury: basic discovery to drug development. Circ. J. 76, 1811-1818
89. Rinaldi, B., Pieri, L., Donniacuo, M., Cappetta, D., Capuano, A., Domenici, L., Carnuccio, R., Romagnoli, P., Filippelli, A. and Rossi, F. (2009) Rosiglitazone reduces the inflammatory response in a model of vascular injury in rats. Shock 32, 638-644
90. Davies, N. M., Jamali, F. and Skeith, K. J. (1996) Nonsteroidal antiinflammatory drug-induced enteropathy and severe chronic anemia in a patient with rheumatoid arthritis. Arthritis Rheum. 39, 321-324
91. Donath, M. Y. (2013) Targeting inflammation in the treatment of type 2 diabetes. Diabetes Obes. Metab. 15 (Suppl. 3), 193-196
92. Murthy, S. N., Desouza, C. V., Bost, N. W., Hilaire, R. C., Casey, D. B., Badejo, A. M., Dhaliwal, J. S., McGee, J., McNamara, D. B., Kadowitz, P. J. and Fonseca, V. A. (2010) Effects of salsalate therapy on recovery from vascular injury in female Zucker fatty rats. Diabetes 59, 3240-3246
93. van der Flier, A. and Sonnenberg, A. (2001) Function and interactions of integrins. Cell. Tissue Res. 305, 285-298
94. Springer, T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314
95. Braun, A., Dofiles, L., Rousselle, S., Guerrero, L., Gunther, J., Yednock, T., Stricker-Krongrad, A. and Messersmith, E. (2010) Effects of an a-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placement. PLoS ONE 5, e14314 96 Karki, R., Kim, S. B. and Kim, D. W. (2013) Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation. Exp. Cell Res. 319, 3238-3250
96. Karki, R., Kim, S. B. and Kim, D. W. (2013) Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation. Exp. Cell Res. 319, 3238-3250
97. Azevedo, L. C., Pedro, M. A., Souza, L. C., de Souza, H. P., Janiszewski, M., da Luz, P. L. and Laurindo, F. R. (2000) Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc. Res. 47, 436-445
98. Juni, R. P., Duckers, H. J., Vanhoutte, P. M., Virmani, R. and Moens, A. L. (2013) Oxidative stress and pathological changes after coronary artery interventions. J. Am. Coll. Cardiol. 61, 1471-1481
99. Baur, J. A. and Sinclair, D. A. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov 5, 493-506
100. Li, H., Xia, N. and Forstermann, U. (2012) Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26, 102-110
101. Zhang, Q. J., Wang, Z., Chen, H. Z., Zhou, S., Zheng, W., Liu, G., Wei, Y. S., Cai, H., Liu, D. P. and Liang, C. C. (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc. Res. 80, 191-199
102. Csiszar, A., Labinskyy, N., Podlutsky, A., Kaminski, P. M., Wolin, M. S., Zhang, C., Mukhopadhyay, P., Pacher, P., Hu, F., de Cabo, R., Ballabh, P. and Ungvari, Z. (2008) Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol. Heart Circ. Physiol. 294, H2721-H2735
103. Zhang, J., Chen, J., Yang, J., Xu, C. W., Pu, P., Ding, J. W. and Jiang, H. (2013) Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kB pathway. Cell. Physiol. Biochem. 31, 230-241
104. Kleinedler, J. J., Foley, J. D., Orchard, E. A. and Dugas, T. R. (2012) Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization. J. Control. Release 159, 27-33
105. Becker, A., Henry, R. M., Kostense, P. J., Jakobs, C., Teerlink, T., Zweegman, S., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M. et al. (2003) Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals. The Hoorn Study. Atherosclerosis 169, 323-330
106. Jeon, B. R. and Lee, S. M. (2001) S-adenosylmethionine protects post-ischemic mitochondrial injury in rat liver. J. Hepatol. 34, 395-401
107. Caro, A. A. and Cederbaum, A. I. (2004) Antioxidant properties of S-adenosyl-L-methionine in Fe2+ -initiated oxidations. Free Radic. Biol. Med. 36, 1303-1316
108. Lim, S., Moon, M. K., Shin, H., Kim, T. H., Cho, B. J., Kim, M., Park, H. S., Choi, S. H., Ko, S. H., Chung, M. H. et al. (2011) Effect of S-adenosylmethionine on neointimal formation after balloon injury in obese diabetic rats. Cardiovasc. Res. 90, 383-393
109. Orlandi, A. and Bennett, M. (2010) Progenitor cell-derived smooth muscle cells in vascular disease. Biochem. Pharmacol. 79, 1706-1713
110. Forte, A., Della Corte, A., De Feo, M., Cerasuolo, F. and Cipollaro, M. (2010) Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm. Cardiovasc. Res. 88, 395-405
111. Heldin, C. H. and Westermark, B. (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316
112. Loseth, O. P., de Lecea, L., Calbet, M., Danielson, P. E., Gautvik, V., Hovring, P. I., Walaas, S. I. and Gautvik, K. M. (2000) Developmental regulation of two isoforms of Ca2+ /calmodulin-dependent protein kinase Iß in rat brain. Brain Res. 869, 137-145
113. Yan, S., Li, M., Chai, H., Yang, H., Lin, P. H., Yao, Q. and Chen, C. (2005) TNF-a decreases expression of somatostatin, somatostatin receptors, and cortistatin in human coronary endothelial cells. J. Surg. Res. 123, 294-301
114. Deghenghi, R., Papotti, M., Ghigo, E. and Muccioli, G. (2001) Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J. Endocrinol. Invest. 24, RC1-RC3
115. Rossi, F., Castelli, A., Bianco, M. J., Bertone, C., Brama, M. and Santiemma, V. (2009) Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP/PKA pathway activation. Atherosclerosis 203, 97-104
116. Duran-Prado, M., Morell, M., Delgado-Maroto, V., Castano, J. P., Aneiros-Fernandez, J., de Lecea, L., Culler, M. D., Hernandez-Cortes, P., O'Valle, F. and Delgado, M. (2013) Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation. Circ. Res. 112, 1444-1455
117. Choi, S. E., Jang, H. J., Kang, Y., Jung, J. G., Han, S. J., Kim, H. J., Kim, D. J. and Lee, K. W. (2010) Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice. Vascul. Pharmacol. 53, 264-272
118. McAlpine, C. S., Bowes, A. J., Khan, M. I., Shi, Y. and Werstuck, G. H. (2012) Endoplasmic reticulum stress and glycogen synthase kinase-3ß activation in apolipoprotein E-deficient mouse models of accelerated atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 82-91
119. Zhu, L., Sun, G., Zhang, H., Zhang, Y., Chen, X., Jiang, X., Krauss, S., Zhang, J., Xiang, Y. and Zhang, C. Y. (2009) PGC-1a is a key regulator of glucose-induced proliferation and migration in vascular smooth muscle cells. PLoS ONE 4, e4182
120. Wang, Z., Zhang, X., Chen, S., Wang, D., Wu, J., Liang, T. and Liu, C. (2013) Lithium chloride inhibits vascular smooth muscle cell proliferation and migration and alleviates injury-induced neointimal hyperplasia via induction of PGC-1a. PLoS ONE 8, e55471
121. Bonoczk, P., Gulyas, B., Adam-Vizi, V., Nemes, A., Karpati, E., Kiss, B., Kapas, M., Szantay, C., Koncz, I., Zelles, T. and Vas, A. (2000) Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Res. Bull. 53, 245-254
122. Cai, Y., Knight, W. E., Guo, S., Li, J. D., Knight, P. A. and Yan, C. (2012) Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J. Pharmacol. Exp. Ther. 343, 479-488
123. Karagiannis, T. C., Lin, A. J., Ververis, K., Chang, L., Tang, M. M., Okabe, J. and El-Osta, A. (2010) Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. Aging (Albany NY) 2, 659-668
124. Kee, H. J., Kwon, J. S., Shin, S., Ahn, Y., Jeong, M. H. and Kook, H. (2011) Trichostatin A prevents neointimal hyperplasia via activation of Kruppel like factor 4. Vascul. Pharmacol. 55, 127-134
125. Tzeng, B. H., Chen, Y. H., Huang, C. H., Lin, S. S., Lee, K. R. and Chen, C. C. (2012) The Cav3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice. Cardiovasc. Res. 96, 533-542
126. Maurel, B., Chai, F., Maton, M., Blanchemain, N. and Haulon, S. (2013) In stent restenosis and thrombosis assessment after EP224283 injection in a rat model. Atherosclerosis 229, 462-468
127. Nabzdyk, C. S., Chun, M., Pradhan Nabzdyk, L., Yoshida, S. and LoGerfo, F. W. (2012) Differential susceptibility of human primary aortic and coronary artery vascular cells to RNA interference. Biochem. Biophys. Res. Commun. 425, 261-265
128. Majesky, M. W. (2007) Developmental basis of vascular smooth muscle diversity. Arterioscler. Thromb. Vasc. Biol. 27, 1248-1258
129. Palmerini, T., Biondi-Zoccai, G., Della Riva, D., Stettler, C., Sangiorgi, D., D'Ascenzo, F., Kimura, T., Briguori, C., Sabate, M., Kim, H. S. et al. (2012) Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 379, 1393-1402
130. King, L., Byrne, R. A., Mehilli, J., Schomig, A., Kastrati, A. and Pache, J. (2013) Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial. Catheter. Cardiovasc. Interv. 81, E23-28
131. Yao, E. H., Fukuda, N., Ueno, T., Matsuda, H., Nagase, H., Matsumoto, Y., Sugiyama, H. and Matsumoto, K. (2009) A pyrrole-imidazole polyamide targeting transforming growth factor-ß1 inhibits restenosis and preserves endothelialization in the injured artery. Cardiovasc. Res. 81, 797-804
132. Forte, A., Grossi, M., Turczynska, K. M., Svedberg, K., Rinaldi, B., Donniacuo, M., Holm, A., Baldetorp, B., Vicchio, M., De Feo, M. et al. (2013) Local inhibition of ornithine decarboxylase reduces vascular stenosis in a murine model of carotid injury. Int. J. Cardiol. 168, 3370-3380
133. Forte, A., Hellstrand, P., Nilsson, B. O., Grossi, M., Rossi, F. and Cipollaro, M. (2011) The polyamine pathway as a potential target for vascular diseases: focus on restenosis. Curr. Vasc. Pharmacol. 9, 706-714
134. Yoon, J. W., Cho, B. J., Park, H. S., Kang, S. M., Choi, S. H., Jang, H. C., Shin, H., Lee, M. J., Kim, Y. B., Park, K. S. and Lim, S. (2013) Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats. Int. J. Cardiol. 167, 126-133
135. Lopatin Iu, M. and Dronova, E. P. (2009) Clinical-pharmacoeconomic aspects of trimetazidine modified release use in patients with ischemic heart disease undergoing coronary artery bypass grafting. Kardiologiia 49, 15-21
136. Hata, M., Yoshitake, I., Wakui, S., Unosawa, S., Kimura, H., Hata, H. and Shiono, M. (2011) Long-term patency rate for radial artery vs. saphenous vein grafts using same-patient materials. Circ. J. 75, 1373-1377
137. Magee, M. J., Alexander, J. H., Hafley, G., Ferguson, Jr, T. B., Gibson, C. M., Harrington, R. A., Peterson, E. D., Califf, R. M., Kouchoukos, N. T., Herbert, M. A. and Mack, M. J. (2008) Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. Ann. Thorac. Surg. 85, 494-499
138. Chung, I. M., Kim, J., Pak, Y. K., Jang, Y., Yang, W. I., Han, I., Park, S. J., Park, S. W., Huh, J., Wight, T. N. and Ueno, H. (2010) Blockade of TGF-ß by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries. Int. J. Cardiol. 145, 468-475
139. Bechler, S. L., Si, Y., Yu, Y., Ren, J., Liu, B. and Lynn, D. M. (2013) Reduction of intimal hyperplasia in injured rat arteries promoted by catheter balloons coated with polyelectrolyte multilayers that contain plasmid DNA encoding PKCd. Biomaterials 34, 226-236
140. Yang, J., Jiang, H., Chen, S. S., Chen, J., Li, W. Q., Xu, S. K. and Wang, J. C. (2010) Lentivirus-mediated RNAi targeting CREB binding protein attenuates neointimal formation and promotes re-endothelialization in balloon injured rat carotid artery. Cell. Physiol. Biochem. 26, 441-448
141. Robertson, K. E., McDonald, R. A., Oldroyd, K. G., Nicklin, S. A. and Baker, A. H. (2012) Prevention of coronary in-stent restenosis and vein graft failure: does vascular gene therapy have a role? Pharmacol. Ther. 136, 23-34
142. White, K. M., Alba, R., Parker, A. L., Wright, A. F., Bradshaw, A. C., Delles, C., McDonald, R. A. and Baker, A. H. (2013) Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile. J. Cardiothorac. Surg. 8, 183
143. George, S. J., Wan, S., Hu, J., MacDonald, R., Johnson, J. L. and Baker, A. H. (2011) Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation 124, S135-S142
144. Lompre, A. M., Hadri, L., Merlet, E., Keuylian, Z., Mougenot, N., Karakikes, I., Chen, J., Atassi, F., Marchand, A., Blaise, R. et al. (2013) Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy. Gene Ther. 20, 901-912
145. Chick, H. E., Nowrouzi, A., Fronza, R., McDonald, R. A., Kane, N. M., Alba, R., Delles, C., Sessa, W. C., Schmidt, M., Thrasher, A. J. and Baker, A. H. (2012) Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk. Hum. Gene Ther. 23, 1247-1257
146. Zheng, H., Xue, S., Lian, F. and Wang, Y. Y. (2011) A novel promising therapy for vein graft restenosis: overexpressed Nogo-B induces vascular smooth muscle cell apoptosis by activation of the JNK/p38 MAPK signaling pathway. Med. Hypotheses 77, 278-281
147. von der Leyen, H. E., Mugge, A., Hanefeld, C., Hamm, C. W., Rau, M., Rupprecht, H. J., Zeiher, A. M. and Fichtlscherer, S. (2011) A prospective, single-blind, multicenter, dose escalation study of intracoronary iNOS lipoplex (CAR-MP583) gene therapy for the prevention of restenosis in patients with de novo or restenotic coronary artery lesion (REGENT I extension). Hum. Gene Ther. 22, 951-958
148. Hedman, M., Muona, K., Hedman, A., Kivela, A., Syvanne, M., Eranen, J., Rantala, A., Stjernvall, J., Nieminen, M. S., Hartikainen, J. and Yla-Herttuala, S. (2009) Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer. Gene Ther. 16, 629-634
149. Zee, R. Y., Hoh, J., Cheng, S., Reynolds, R., Grow, M. A., Silbergleit, A., Walker, K., Steiner, L., Zangenberg, G., Fernandez-Ortiz, A. et al. (2002) Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease. Pharmacogenomics J. 2, 197-201
150. Okamura, A., Ohishi, M., Rakugi, H., Katsuya, T., Yanagitani, Y., Takiuchi, S., Taniyama, Y., Moriguchi, K., Ito, H., Higashino, Y. et al. (1999) Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty. Angiology 50, 811-822
151. Goodarzi, M. O., Taylor, K. D., Scheuner, M. T., Antoine, H. J., Guo, X., Shah, P. K. and Rotter, J. I. (2007) Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts. Pharmacogenomics J. 7, 66-73
152. Jacobs, J., Shah, A., Zinn, A. and Levine, J. (2012) Coronary stent thrombosis in patients undergoing multidigit replantation. Crit. Care Med. 40, 285-289
153. Sun, S. G., Zheng, B., Han, M., Fang, X. M., Li, H. X., Miao, S. B., Su, M., Han, Y., Shi, H. J. and Wen, J. K. (2011) miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep. 12, 56-62
154. Torella, D., Iaconetti, C., Catalucci, D., Ellison, G. M., Leone, A., Waring, C. D., Bochicchio, A., Vicinanza, C., Aquila, I., Curcio, A., Condorelli, G. and Indolfi, C. (2011) MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ. Res. 109, 880-893
155. Merlet, E., Atassi, F., Motiani, R. K., Mougenot, N., Jacquet, A., Nadaud, S., Capiod, T., Trebak, M., Lompre, A. M. and Marchand, A. (2013) miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovasc. Res. 98, 458-468
156. McDonald, R. A., White, K. M., Wu, J., Cooley, B. C., Robertson, K. E., Halliday, C. A., McClure, J. D., Francis, S., Lu, R., Kennedy, S. et al. (2013) miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. Eur. Heart J. 34, 1636-1643
157. Lipskaia, L., Hadri, L., Le Prince, P., Esposito, B., Atassi, F., Liang, L., Glorian, M., Limon, I., Lompre, A. M., Lehoux, S. and Hajjar, R. J. (2013) SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery. Gene Ther. 20, 396-406
158. Silvestre-Roig, C., Fernandez, P., Esteban, V., Pello, O. M., Indolfi, C., Rodriguez, C., Rodriguez-Calvo, R., Lopez-Maderuelo, M. D., Bauriedel, G., Hutter, R. et al. (2013) Inactivation of nuclear factor-Y inhibits vascular smooth muscle cell proliferation and neointima formation. Arterioscler. Thromb. Vasc. Biol. 33, 1036-1045
159. Larifla, L., Deprez, I., Pham, I., Rideau, D., Louzier, V., Adam, M., Eloit, M., Foucan, L., Adnot, S. and Teiger, E. (2012) Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery. J. Gene Med. 14, 459-467
160. Joung, H., Kwon, J. S., Kim, J. R., Shin, S., Kang, W., Ahn, Y., Kook, H. and Kee, H. J. (2012) Enhancer of polycomb1 lessens neointima formation by potentiation of myocardin-induced smooth muscle differentiation. Atherosclerosis 222, 84-91
161. Jacob, T., Hingorani, A. and Ascher, E. (2012) p53 gene therapy modulates signal transduction in the apoptotic and cell cycle pathways downregulating neointimal hyperplasia. Vasc. Endovascular Surg. 46, 45-53